BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, December 29, 2025
Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

Questcor Raises $5M To Fund $18.2M Purchase Of Nascobal

June 18, 2003
By Aaron Lorenzo

Cytogen Regains Rights To Berlex's Cancer Pain Product

June 17, 2003
By Aaron Lorenzo

ICOS Planning To Raise $250M Through Private Sale Of Notes

June 17, 2003
By Aaron Lorenzo
ICOS Corp. is looking to raise $250 million through an offering of convertible subordinated notes. (BioWorld Today)
Read More

Cytogen Regains Rights To Berlex's Cancer Pain Product

June 17, 2003
By Aaron Lorenzo

ICOS Planning To Raise $250M Through Private Sale Of Notes

June 17, 2003
By Aaron Lorenzo
ICOS Corp. is looking to raise $250 million through an offering of convertible subordinated notes. (BioWorld Today)
Read More

Exelixis Plans To Sell 10 Million Shares Through Public Offering

June 16, 2003
By Aaron Lorenzo

Exelixis Plans To Sell 10 Million Shares Through Public Offering

June 16, 2003
By Aaron Lorenzo

Pozen Licenses Migraine Drug To GSK In Potential $160M Deal

June 13, 2003
By Aaron Lorenzo
Pozen Inc. could garner up to at least $160 million after entering a deal with GlaxoSmithKline plc surrounding a migraine treatment. (BioWorld Today)
Read More

Pozen Licenses Migraine Drug To GSK In Potential $160M Deal

June 13, 2003
By Aaron Lorenzo
Pozen Inc. could garner up to at least $160 million after entering a deal with GlaxoSmithKline plc surrounding a migraine treatment. (BioWorld Today)
Read More

NPS Planning To Sell $125M In Notes After Merger Talks End

June 12, 2003
By Aaron Lorenzo
Previous 1 2 … 187 188 189 190 191 192 193 194 195 … 237 238 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 29, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 29, 2025.
  • Illustration of magnifying glass looking at cancer in the brain

    Researchers discover how glioblastoma tumors dodge chemotherapy

    BioWorld MedTech
    Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
  • Businessman, businesswoman handshake

    Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact

    BioWorld
    Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
  • Asia focused map inside light bulb

    Big pharma taps fast Asia innovation in search of next Keytruda

    BioWorld
    Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing